In conclusion, these findings suggest that increased peripheral IL-6 signaling and altered composition of the gut microbiota may have an important role in the pathogenesis of depression and that IL-6 receptor antibody MR16-1 showed rapid-onset and long-lasting antidepressant effects through the modulation of the immune system. Here, IL6 is linked to depressive symptom measurement.